SBX.DE
Price:
$1.68
Market Cap:
$9.49M
SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-01-07
Stock Exchange
XETRA
Ticker
SBX.DE
According to SynBiotic SE’s latest financial reports and current stock price. The company's current PE Ratio is -0.75. This represents a change of -90.14% compared to the average of -7.61 of the last 4 quarters.
The mean historical PE Ratio of SynBiotic SE over the last ten years is -6853.21. The current -0.75 PE Ratio has changed -98.91% with respect to the historical average. Over the past ten years (40 quarters), SBX.DE's PE Ratio was at its highest in in the December 2021 quarter at 0. The PE Ratio was at its lowest in in the June 2020 quarter at -128.49.
Average
-6853.21
Median
-22.90
Minimum
-40655.94
Maximum
-1.32
Discovering the peaks and valleys of SynBiotic SE PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -1.32
Minimum Annual Increase = -98.98%
Minimum Annual PE Ratio = -40655.94
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -1.32 | -25.76% |
| 2022 | -1.77 | -75.10% |
| 2021 | -7.12 | -81.58% |
| 2020 | -38.67 | -90.67% |
| 2019 | -414.44 | -98.98% |
The current PE Ratio of SynBiotic SE (SBX.DE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.41
5-year avg
-92.67
10-year avg
-6853.21
SynBiotic SE’s PE Ratio is greater than Maternus-Kliniken AG (-1.47), greater than aap Implantate AG (-6.91), greater than NanoRepro AG (-9.53), less than Geratherm Medical AG (8.43), greater than Oakridge International Limited (-17.78), less than AS Latvijas Juras medicinas centrs (25.92), greater than elexxion AG (-1.31),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.47 | $22.23M | |
| -6.91 | $19.05M | |
| -9.53 | $19.49M | |
| 8.43 | $16.99M | |
| -17.78 | $809.94K | |
| 25.92 | $6.72M | |
| -1.31 | $1.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SynBiotic SE using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like SynBiotic SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is SynBiotic SE's PE Ratio?
How is the PE Ratio calculated for SynBiotic SE (SBX.DE)?
What is the highest PE Ratio for SynBiotic SE (SBX.DE)?
What is the 3-year average PE Ratio for SynBiotic SE (SBX.DE)?
What is the 5-year average PE Ratio for SynBiotic SE (SBX.DE)?
How does the current PE Ratio for SynBiotic SE (SBX.DE) compare to its historical average?